Abstract
Both classic and emerging literature point to sex-based disparity in neuronal metabolism. While detectable under baseline conditions, this phenomenon appears to be exaggerated or sometimes unmasked in neurons by cellular stress. A complex sex-dependent response to nutrient deprivation, excitotoxicity, oxidative/nitrositive stress, oxygen-glucose deprivation, and chemical toxicity has been observed in neurons in vitro, as well as after various insults including ischemic or traumatic brain injury in vivo. Importantly, sex-based disparity in response to diverse therapeutics has been seen in neurons in culture, contemporary animal models of brain injury, and in human disease. These have clear implications for pharmacological design of therapeutics targeting central nervous system diseases involving both males and females, and preclinical testing of promising agents.
Keywords: Apoptosis, autophagy, gender, oxidative stress, nitrosative stress, nutrient deprivation, starvation, neuronal metabolism, ischemia, cachexia
Current Pharmaceutical Design
Title: Unmasking Sex-Based Disparity in Neuronal Metabolism
Volume: 17 Issue: 35
Author(s): Mioara D. Manole, Roya Tehranian-DePasquale, Lina Du, Hulya Bayır, Patrick M. Kochanek and Robert S.B. Clark
Affiliation:
Keywords: Apoptosis, autophagy, gender, oxidative stress, nitrosative stress, nutrient deprivation, starvation, neuronal metabolism, ischemia, cachexia
Abstract: Both classic and emerging literature point to sex-based disparity in neuronal metabolism. While detectable under baseline conditions, this phenomenon appears to be exaggerated or sometimes unmasked in neurons by cellular stress. A complex sex-dependent response to nutrient deprivation, excitotoxicity, oxidative/nitrositive stress, oxygen-glucose deprivation, and chemical toxicity has been observed in neurons in vitro, as well as after various insults including ischemic or traumatic brain injury in vivo. Importantly, sex-based disparity in response to diverse therapeutics has been seen in neurons in culture, contemporary animal models of brain injury, and in human disease. These have clear implications for pharmacological design of therapeutics targeting central nervous system diseases involving both males and females, and preclinical testing of promising agents.
Export Options
About this article
Cite this article as:
D. Manole Mioara, Tehranian-DePasquale Roya, Du Lina, Bayır Hulya, M. Kochanek Patrick and S.B. Clark Robert, Unmasking Sex-Based Disparity in Neuronal Metabolism, Current Pharmaceutical Design 2011; 17 (35) . https://dx.doi.org/10.2174/138161211798357737
DOI https://dx.doi.org/10.2174/138161211798357737 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gene Therapy as a Novel Pharmaceutical Intervention for Stroke
Current Pharmaceutical Design Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer’s Disease
Current Alzheimer Research Hypothyroidism and High Plasma and Urine Iodine Levels Related to the Use of Gastrografin
Current Pediatric Reviews Relation Between Obstructive Sleep Apnea Syndrome and Resistant Hypertension - The Tip of the Iceberg
Current Respiratory Medicine Reviews Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?
Medicinal Chemistry Reviews - Online (Discontinued) Meet Our Editorial Board Member
Current Alzheimer Research COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?
CNS & Neurological Disorders - Drug Targets Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis
Current Drug Metabolism Microglia in Alzheimer's Disease: The Good, the Bad and the Ugly
Current Alzheimer Research Noninvasive Diagnosis of Chemotherapy Related Cardiotoxicity
Current Cardiology Reviews Tailored Angiogenesis Inhibition in Cancer Therapy: Respecting the Heart to Improve the Net Outcome
Current Signal Transduction Therapy Heart Failure in Acute Ischemic Stroke
Current Cardiology Reviews Microglial Integrity is Maintained by Erythropoietin Through Integration of Akt and Its Substrates of lycogen Synthase Kinase-3β, β-Catenin, and Nuclear Factor-κB
Current Neurovascular Research The Glioblastoma Problem: Targeting by Combined Medicinal Chemistry Approaches
Current Medicinal Chemistry Reduction of Oxidative/Nitrosative Stress in Brain and its Involvement in the Neuroprotective Effect of n-3 PUFA in Alzheimer’s Disease
Current Alzheimer Research Cellular Balance, Genes,and the Huang Ti Nei Ching Su Wen
Current Neurovascular Research Recent progress in the development of anthrax vaccines
Recent Patents on Biotechnology Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry Harnessing the Capacity of Cell-Penetrating Peptides for Drug Delivery to the Central Nervous System
Current Pharmaceutical Biotechnology Animal Models Used for the Evaluation of Antiretroviral Therapies
Current HIV Research